With biomanufacturing faciliites in Kansas, and offices in Aurora CO, Ventria Bioscience - formerly dba as Applied Phytologics, Inc. (API),- is a biopharmaceutical company with a product pipeline enabled by ExpressTec.- a patented, plant-based recombinant protein manufacturing technology that delivers a ten-fold higher recombinant protein yield than other plant-based systems. ExpressTec supports production of recombinant proteins, small peptides, multi-subunit molecules, monoclonal antibodies, fusion proteins, and enzymes used in medicine and biotechnology. However, ExpressTec proteins are manufactured within a growing plant instead of in a stainless steel bioreactor, using sunlight for an energy source and soil, water, and air as raw materials. This pllatform technology delivers the development of new biotherapeutics, novel vaccines, reagents for biomanufacturing, and industrial and biofuel enzymes. Ventria Bioscience's internal Therapeutic Pipeline includes new human therapeutic products and vaccines for controlling zoonotic disease. Ventria Bioscience also provides access to its platform technology through contract manufacturing services. Ventria Bioscience has an extensive intellectual property portfolio of more than 100 issued patents, exclusive licenses to issued patents, and patents in prosecution.